These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Significant elevation of B cells at the acute stage in enterovirus 71-infected children with central nervous system involvement. Xie J, Jiao Y, Qiu Z, Li Q, Li T. Scand J Infect Dis; 2010 Dec; 42(11-12):931-5. PubMed ID: 20950217 [Abstract] [Full Text] [Related]
27. Generation and characterization of a protective mouse monoclonal antibody against human enterovirus 71. Deng YQ, Ma J, Xu LJ, Li YX, Zhao H, Han JF, Tao J, Li XF, Zhu SY, Qin ED, Qin CF. Appl Microbiol Biotechnol; 2015 Sep; 99(18):7663-71. PubMed ID: 25967656 [Abstract] [Full Text] [Related]
28. Cross-reactivity of anti-EV71 IgM and neutralizing antibody in series sera of patients infected with Enterovirus 71 and Coxsackievirus A 16. Lin Y, Wen K, Pan Y, Wang Y, Che X, Wang B. J Immunoassay Immunochem; 2011 Sep; 32(3):233-43. PubMed ID: 21574094 [Abstract] [Full Text] [Related]
29. Characterization of enterovirus 71 capsids using subunit protein-specific polyclonal antibodies. Liu Q, Huang X, Ku Z, Wang T, Liu F, Cai Y, Li D, Leng Q, Huang Z. J Virol Methods; 2013 Jan; 187(1):127-31. PubMed ID: 23046991 [Abstract] [Full Text] [Related]
31. Neutralization Mechanisms of Two Highly Potent Antibodies against Human Enterovirus 71. Zhu L, Xu K, Wang N, Cao L, Wu J, Gao Q, Fry EE, Stuart DI, Rao Z, Wang J, Wang X. mBio; 2018 Jul 03; 9(4):. PubMed ID: 29970466 [Abstract] [Full Text] [Related]
39. Neutralizing antibody response in the patients with hand, foot and mouth disease to enterovirus 71 and its clinical implications. Yang C, Deng C, Wan J, Zhu L, Leng Q. Virol J; 2011 Jun 16; 8():306. PubMed ID: 21679417 [Abstract] [Full Text] [Related]